B
Beijing Succeeder Technology Inc
SSE:688338
Beijing Succeeder Technology Inc
SSE:688338
Price:
29.1
CNY
-1.36%
Market Closed
Market Cap:
¥3.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Beijing Succeeder Technology Inc
SSE:688338
|
CN |
|
S
|
Shrenik Ltd
NSE:SHRENIK
|
IN |
|
V
|
Vcanbio Cell & Gene Engineering Corp Ltd
SSE:600645
|
CN |
|
Bank of Communications Co Ltd
SSE:601328
|
CN |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
US |
|
Ishikawa Seisakusho Ltd
TSE:6208
|
JP |
|
KKR & Co Inc
NYSE:KKR
|
US |
|
L
|
Landing International Development Ltd
HKEX:582
|
HK |
|
Shenzhen H&T Intelligent Control Co Ltd
SZSE:002402
|
CN |
|
C
|
Componenta Oyj
OMXH:CTH1V
|
FI |
|
Mrs. Bectors Food Specialities Ltd
NSE:BECTORFOOD
|
IN |
Income Statement
Earnings Waterfall
Beijing Succeeder Technology Inc
Beijing Succeeder Technology Inc
Income Statement
Beijing Succeeder Technology Inc
Beijing Succeeder Technology Inc
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
238
N/A
|
235
-1%
|
240
+2%
|
229
-5%
|
246
+8%
|
264
+7%
|
269
+2%
|
275
+2%
|
285
+3%
|
293
+3%
|
298
+2%
|
306
+3%
|
299
-2%
|
286
-4%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(98)
|
(96)
|
(97)
|
(86)
|
(95)
|
(101)
|
(103)
|
(102)
|
(107)
|
(111)
|
(118)
|
(118)
|
(122)
|
(118)
|
|
| Gross Profit |
140
N/A
|
140
-1%
|
143
+2%
|
143
0%
|
151
+6%
|
163
+8%
|
166
+2%
|
173
+4%
|
178
+3%
|
182
+3%
|
180
-1%
|
188
+4%
|
177
-6%
|
168
-5%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(59)
|
(57)
|
(60)
|
(60)
|
(58)
|
(64)
|
(64)
|
(69)
|
(70)
|
(72)
|
(77)
|
(85)
|
(81)
|
(79)
|
|
| Selling, General & Administrative |
(46)
|
(44)
|
(42)
|
(44)
|
(44)
|
(48)
|
(50)
|
(53)
|
(54)
|
(56)
|
(58)
|
(60)
|
(64)
|
(62)
|
|
| Research & Development |
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(18)
|
(18)
|
(18)
|
(20)
|
(21)
|
(21)
|
(18)
|
(19)
|
(19)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
|
| Other Operating Expenses |
2
|
3
|
(2)
|
2
|
3
|
2
|
4
|
4
|
4
|
4
|
2
|
3
|
2
|
2
|
|
| Operating Income |
81
N/A
|
83
+2%
|
83
+1%
|
83
-1%
|
93
+12%
|
99
+6%
|
102
+3%
|
104
+2%
|
108
+4%
|
110
+2%
|
103
-6%
|
103
0%
|
96
-7%
|
89
-7%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
26
|
31
|
35
|
35
|
35
|
34
|
31
|
31
|
32
|
27
|
25
|
27
|
26
|
24
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Total Other Income |
4
|
4
|
6
|
2
|
2
|
2
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
111
N/A
|
118
+6%
|
124
+5%
|
120
-3%
|
130
+8%
|
135
+4%
|
133
-2%
|
135
+2%
|
139
+3%
|
138
-1%
|
128
-7%
|
130
+1%
|
122
-6%
|
113
-7%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(18)
|
(19)
|
(18)
|
(18)
|
(18)
|
(16)
|
(17)
|
(16)
|
(15)
|
|
| Income from Continuing Operations |
96
|
103
|
109
|
104
|
112
|
117
|
114
|
117
|
121
|
119
|
113
|
113
|
106
|
98
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
96
N/A
|
103
+7%
|
109
+5%
|
104
-4%
|
112
+8%
|
117
+4%
|
114
-3%
|
117
+3%
|
121
+3%
|
119
-1%
|
113
-6%
|
113
+0%
|
106
-6%
|
98
-7%
|
|
| EPS (Diluted) |
1.18
N/A
|
1.26
+7%
|
1.02
-19%
|
0.98
-4%
|
1.05
+7%
|
1.1
+5%
|
1.07
-3%
|
1.1
+3%
|
1.14
+4%
|
1.13
-1%
|
1.06
-6%
|
1.07
+1%
|
1
-7%
|
0.94
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
